Case Study

Method Optimization: Assay Development Following Compendial Methods

Source: Cambrex

Chapter 621 of the USP explains the allowable adjustments to chromatography systems while staying within quality requirements. It is important to consider these criteria before beginning to optimize assays for APIs and related substances to ensure that methods meet requirements during regulatory filing.

In this case, Cambrex had a short time frame of only 7 weeks to complete assay optimization and conduct pre-validation studies within the confines of USP<621&GT. The additional challenges they faced from inherent properties of the API included a narrow pH window (± 0.05 of the pKa), and controlling reaction conditions to allow use of an ion pairing agent. In addition, the analysis time was lengthy (72 minutes), and required evaluation of multiple peaks and PDA spectral evaluation during system suitability.

access the Case Study!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Drug Discovery Online? Subscribe today.

Subscribe to Drug Discovery Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Drug Discovery Online